Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
postdoctoral researcher interested in studying human-associated microbial communities in health and disease. The ideal candidate has the following qualifications: A PhD degree in bioinformatics, computational
-
-katleen-de-preter-phd ). In 2022, an ERC consolidator grant was awarded to her to support the advancement of minimally-invasive assay for epigenetic tumor plasticity monitoring. The TOBI-lab is part of
-
PhD is within relevant area for the MINDFUL project (neurodegenerative diseases, organoid technology using guided and unguided differentiation, experience with microglia, AD and MS). You should be also
-
? You have a strong background (PhD) in single cell/spatial omics technologies and implementation. Having successfully applied state-of-the-art genetic engineering technologies (such as CRISPR/Cas9
-
strong background (PhD) in single cell/spatial omics technologies and implementation. Having successfully applied state-of-the-art genetic engineering technologies (such as CRISPR/Cas9, lineage tracing
-
. Profile You hold a PhD in biomedical sciences, biotechnologies or related disciplines. You have spent at least 12 months of the three years prior to the start date as a postdoctoral scholarship holder
-
well as collaboration with clinicians for human tissue studies. Profile Essential You have an international PhD in physiology, neuroscience, biomedical sciences, or related fields. You are an expert in molecular biology
-
tissue studies. Essential You have an international PhD in physiology, neuroscience, biomedical sciences, or related fields. You are an expert in molecular biology and/or electrophysiology. You are eager
-
activities Undertake teaching at undergraduate and/or post graduate level Your profile The successful candidate(s) will have: An outstanding academic record and a PhD with a specialization in European Law
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based